A new study found that an FDA “healthy” label could influence what foods shoppers choose and how much they’re willing to pay.
The FDA is considering allowing compounding pharmacies to make unproven peptides—sparking fears around efficacy and safety.
A recalled batch of cantaloupes linked to potential Salmonella contamination has been upgraded to a Class I recall by the U.S ...
FDA will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23-24, 2026, to discuss seven peptides for potential inclusion on the 503A bulks list. An additional five peptides will be ...
The Food and Drug Administration on Wednesday announced meeting dates for advisors to discuss lifting restrictions on 12 ...
The FDA meeting announcement follows repeated pledges by Health Secretary Robert F. Kennedy Jr. to loosen regulations on ...
Teplizumab-mzwv is the first disease-modifying therapy available for children as young as 1 year diagnosed with ...
By Ahmed Aboulenein and Puyaan Singh WASHINGTON, April 22 (Reuters) - Health Secretary Robert F. Kennedy Jr. told a Senate ...
The Food and Drug Administration (FDA) is taking the first steps toward potentially easing access to certain peptide ...
Dianthus Therapeutics Inc (NASDAQ:DNTH) is among the best 52-week high US stocks to buy. On March 26, William Blair ...
Idvynso uniquely offers a two-drug, tenofovir-free, non-INSTI single-tablet regimen intended for switch in stable, suppressed ...
By Christy Santhosh and Sriparna Roy April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results